HNB
DNLI icon

Huntington National Bank’s Denali Therapeutics DNLI Stock Holding History

Huntington National Bank’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Buy
445
+25
+6% +$514 ﹤0.01% 1984
2026
Q1 		$8.06K Sell
420
-71
-14% -$1.41K ﹤0.01% 1927
2025
Q4 		$8.11K Buy
491
+183
+59% +$3.09K ﹤0.01% 1853
2025
Q3 		$4.47K Buy
308
+38
+14% +$546 ﹤0.01% 2040
2025
Q2 		$3.78K Sell
270
-423
-61% -$5.95K ﹤0.01% 2082
2025
Q1 		$9.42K Buy
693
+100
+17% +$1.92K ﹤0.01% 1773
2024
Q4 		$12.1K Buy
593
+122
+26% +$3.12K ﹤0.01% 1711
2024
Q3 		$13.7K Buy
471
+26
+6% +$644 ﹤0.01% 1640
2024
Q2 		$10.3K Buy
445
+71
+19% +$1.36K ﹤0.01% 1680
2024
Q1 		$7.67K Buy
374
+24
+7% +$451 ﹤0.01% 1775
2023
Q4 		$7.51K Sell
350
-5
-1% -$99 ﹤0.01% 1748
2023
Q3 		$7.32K Sell
355
-98
-22% -$2.49K ﹤0.01% 1679
2023
Q2 		$13.4K Sell
453
-4
-0.9% -$112 ﹤0.01% 1482
2023
Q1 		$10.5K Buy
457
+116
+34% +$3.19K ﹤0.01% 1514
2022
Q4 		$9.48K Sell
341
-6
-2% -$179 ﹤0.01% 1507
2022
Q3 		$11K Buy
347
+209
+151% +$6.79K ﹤0.01% 1492
2022
Q2 		$4K Hold
138
– – ﹤0.01% 1767
2022
Q1 		$4K Buy
138
+7
+5% +$241 ﹤0.01% 1792
2021
Q4 		$6K Buy
131
+1
+0.8% +$47 ﹤0.01% 1686
2021
Q3 		$7K Buy
+130
New +$7.33K ﹤0.01% 1518

Other funds holding DNLI

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Huntington National Bank's DNLI Position: Q2 2026 in Review

Huntington National Bank increased its Denali Therapeutics (DNLI) stake by 6% in Q2 2026, buying an estimated $514 and bringing the position to 445 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1984.

Huntington National Bank first reported a position in DNLI in Q3 2021 and has held it in 20 quarters since. The position peaked at $13.7K in Q3 2024. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

  • Huntington National Bank held 445 shares of Denali Therapeutics worth $11.4K as of Q2 2026.
  • Huntington National Bank bought 25 Denali Therapeutics shares in Q2 2026, an estimated $514.
  • Denali Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1984 holding.
  • Huntington National Bank first reported a position in Denali Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Huntington National Bank's Denali Therapeutics position peaked at $13.7K in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.